What is monkeypox?
On May 18, and the confirmed a single case of monkeypox in a patient who had recently traveled to Canada. Cases have also been .
Monkeypox isn’t a new disease. The , when the virus was isolated from a child suspected of having smallpox in the Democratic Republic of Congo (DRC). Monkeypox is unlikely to cause another pandemic, but , fear of another major outbreak is understandable. Though rare and usually mild, monkeypox can still potentially cause severe illness. Health officials are concerned that more cases will arise with increased travel.
I’m a researcher who has worked in for over three decades, especially in the realm of diseases with animal origins. What exactly is happening in the current outbreak, and what does history tell us about monkeypox?

A cousin of smallpox
is caused by the monkeypox virus, which belongs to a subset of the Poxviridae family of viruses called Orthopoxvirus. This subset includes the smallpox, and cowpox viruses. While an , African rodents are suspected to play a part in transmission. The monkeypox virus has only been isolated twice from an animal in nature. is currently only available at Laboratory Response Network labs in the U.S. and globally.
The name “monkeypox” comes from the of the illness in animals in 1958, when two outbreaks occurred in monkeys kept for research. However, from monkeys to humans, nor are monkeys major carriers of the disease.
Epidemiology
Since the first reported human case, monkeypox has been found in , with the majority of infections in the DRC. Cases outside of Africa have been linked to international travel or imported animals, including in the U.S. and .
The was in 2003, from an outbreak in Texas linked to a shipment of animals from Ghana. There were also travel-associated cases in in Maryland.
Because monkeypox is closely related to smallpox, the smallpox vaccine can against infection from both viruses. Since smallpox was officially eradicated, however, for the U.S. general population were stopped in 1972. Because of this, monkeypox has been in unvaccinated people.
Transmission
The virus can be through contact with an infected person or animal or contaminated surfaces. Typically, the virus enters the body through broken skin, inhalation or the mucous membranes in the eyes, nose or mouth. Researchers believe that human-to-human transmission is mostly through inhalation of large respiratory droplets rather than direct contact with bodily fluids or indirect contact through clothes. Human-to-human transmission rates for monkeypox have been .
are worried the virus may currently be spreading undetected through community transmission, possibly through a new mechanism or route. Where and how infections are occurring are still under investigation.
Signs and symptoms

After the virus enters the body, it starts to through the body via the bloodstream. Symptoms usually don’t appear until one to two weeks after infection.
Monkeypox produces smallpox-like skin lesions, but are usually milder than those of smallpox. Flu-like symptoms are common initially, ranging from fever and headache to shortness of breath. One to 10 days later, a rash can appear on the extremities, head or torso that eventually turns into blisters filled with pus. Overall, symptoms usually last for two to four weeks, while skin lesions usually scab over in 14 to 21 days.
While monkeypox is rare and usually non-fatal, of the disease kills . The form of the virus currently circulating is thought to be milder, with a fatality rate of less than 1%.
Vaccines and treatments
is primarily focused on relieving symptoms. According to the CDC, no treatments are available to cure monkeypox infection.
Evidence suggests that the smallpox vaccine can help prevent monkeypox infections and decrease the severity of the symptoms. One vaccine known as is licensed in the U.S. to prevent monkeypox and smallpox.
Vaccination after exposure to the virus may also help decrease chances of severe illness. The CDC currently recommends smallpox vaccination only in people who have been or are likely to be exposed to monkeypox. are at high risk.
This article is republished from under a Creative Commons license. Read the .
Enjoy reading 91ÑÇÉ«´«Ã½ Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91ÑÇÉ«´«Ã½ Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Targeting toxins to treat whooping cough
Scientists find that liver protein inhibits of pertussis toxin, offering a potential new treatment for bacterial respiratory disease. Read more about this recent study from the Journal of Biological Chemistry.

Elusive zebrafish enzyme in lipid secretion
Scientists discover that triacylglycerol synthesis enzyme drives lipoproteins secretion rather than lipid droplet storage. Read more about this recent study from the Journal of Biological Chemistry.

Scientists identify pan-cancer biomarkers
Researchers analyze protein and RNA data across 13 cancer types to find similarities that could improve cancer staging, prognosis and treatment strategies. Read about this recent article published in Molecular & Cellular Proteomics.

New mass spectrometry tool accurately identifies bacteria
Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular & Cellular Proteomics.

New tool matches microbial and metabolic metaproteomic data
Scientists develop a bioinformatics program that maps omics data to metabolic pathways. Read about this recent article published in Molecular & Cellular Proteomics

Meet Paul Shapiro
Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.